| Trial name or title |
A protocol for nonmetastatic rhabdomyosarcoma [RMS‐2005] |
| Methods |
Method of randomisation not clear (patients are stratified according to risk group and participating country) |
| Participants |
Children with high‐risk rhabdomyosarcoma (maximal age 20 years) |
| Interventions |
Ifosfamide, vincristine, dactinomycin with or without doxorubicin |
| Outcomes |
Response rate, survival and toxicity |
| Starting date |
June 2006 |
| Contact information |
Study chairs Gianni Bisogno, Meriel Jenney, Joern Treuner and Hans Merks |
| Notes |
It is unclear from the current information if the cumulative doses of agents other than anthracyclines differ less than 25% between study groups. |
